Jul 10 There’s a story living in your beer’s DNA By Catherine Woods Dash Masland has a British fungus hanging on her wall. The fungus, framed in a picture, is beer yeast and the main ingredient in the farmhouse-style beer brewed in her Maine-based microbrewery. It is also her muse. The marine… Continue reading
Jul 09 Biologists manufacture bacteria that may one day treat an unhealthy stomach By Catherine Woods Scientists altered the DNA of a common gut bacteria, Bacteroides Thetaiotaomicron to treat an unhealthy stomach and make poop glow. Continue reading
Jul 08 The ant, the butterfly and their chemical warfare with an oregano plant By Nsikan Akpan When pushed to the brink by ant invaders, oregano uses chemical warfare to call in butterfly reinforcements. Continue reading
May 14 Poking cells, solving mysteries and other reasons scientists love basic research By Rebecca Jacobson, Inside Energy Scientists and engineers frequently seek solutions to specific problems. But the goal -- and challenge -- of basic research is to tackle broad questions without an immediate application in mind. As part of our ongoing series on the subject, PBS… Continue reading
May 13 Watch NewsHour asks: why do you choose basic research? By Rebecca Jacobson, Inside Energy Continue watching
Feb 12 Science students, why did you choose basic research? By Bridget Shirvell We want to know more about why students who are focusing on basic research have made that decision. What about it excites you? Frustrates you?… Continue reading
Jan 22 What a glowing green worm can teach us about our immune systems By Rebecca Jacobson, Inside Energy Dennis Kim, associate professor of biology at MIT, spends his days carefully raising worms that are no bigger than a comma. The students in his lab feed them, watching them grow and multiply on petri dishes that sit in a… Continue reading
Mar 26 U.S. Seeks AIDS Vaccine Research Overhaul By Admin, PBS News Hour The head of the federal government's AIDS vaccine research program said Tuesday that the focus should shift from large-scale human vaccine trials back to basic research. Continue reading